Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Bibliografiset tiedot
Päätekijät:	Sebastian, S, Lambe, T
Aineistotyyppi:	Journal article
Julkaistu:	MDPI 2018

Samankaltaisia teoksia

Clinical Advances in Viral-Vectored Influenza Vaccines
Tekijä: Sarah Sebastian, et al.
Julkaistu: (2018-05-01)

Viral vector vaccines
Tekijä: McCann, N, et al.
Julkaistu: (2022)

Clinical development of viral vectored vaccines against MERS-COV
Tekijä: Ewer, K, et al.
Julkaistu: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
Tekijä: D. A. Mezhenskaia, et al.
Julkaistu: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Tekijä: Bissett, C, et al.
Julkaistu: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
Tekijä: Cameron Bissett, et al.
Julkaistu: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
Tekijä: Arunkumar, G, et al.
Julkaistu: (2019)

Research advances in replication-deficient viral vector vaccines
Tekijä: Junna Wang, et al.
Julkaistu: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
Tekijä: McMahon, M, et al.
Julkaistu: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
Tekijä: Antrobus, R
Julkaistu: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
Tekijä: Tully, C, et al.
Julkaistu: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
Tekijä: Tully, C
Julkaistu: (2015)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
Tekijä: Mullin, J, et al.
Julkaistu: (2014)

Development of viral vectors for passive immunisation against influenza
Tekijä: Tan, TK
Julkaistu: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
Tekijä: Marta Ulaszewska, et al.
Julkaistu: (2023-01-01)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
Tekijä: Irina Isakova-Sivak, et al.
Julkaistu: (2022-07-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
Tekijä: Antrobus, R, et al.
Julkaistu: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Tekijä: Antrobus, R, et al.
Julkaistu: (2014)

Adenoviral vectors as novel vaccines for influenza.
Tekijä: Coughlan, L, et al.
Julkaistu: (2015)

Virus-Vectored Influenza Virus Vaccines
Tekijä: Ralph A. Tripp, et al.
Julkaistu: (2014-08-01)

Viral vectors for malaria vaccine development.
Tekijä: Li, S, et al.
Julkaistu: (2007)

The use of viral vectors in vaccine development
Tekijä: Tatianna Travieso, et al.
Julkaistu: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
Tekijä: Kenneth Lundstrom
Julkaistu: (2016-11-01)

Developments in Viral Vector-Based Vaccines
Tekijä: Takehiro Ura, et al.
Julkaistu: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
Tekijä: Kapulu, MC
Julkaistu: (2014)

Recombinant influenza A viruses as vaccine vectors
Tekijä: Thomas Gerlach, et al.
Julkaistu: (2019-04-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Katie Ewer, et al.
Julkaistu: (2017-12-01)

Viral vectors as vaccine platforms: Deployment in sight
Tekijä: Rollier, C, et al.
Julkaistu: (2011)

Novel viral vector vaccines for tropical infections
Tekijä: Rampling, T
Julkaistu: (2017)

Viral vectors as vaccine platforms: deployment in sight.
Tekijä: Rollier, C, et al.
Julkaistu: (2011)

Viral Vectors for COVID-19 Vaccine Development
Tekijä: Kenneth Lundstrom
Julkaistu: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
Tekijä: Luis Jiménez-Cabello, et al.
Julkaistu: (2020-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
Tekijä: Sushmita Kumari, et al.
Julkaistu: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
Tekijä: Jianfeng Zhang
Julkaistu: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
Tekijä: Shintaro Shichinohe, et al.
Julkaistu: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
Tekijä: L. M. Khantimirova, et al.
Julkaistu: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
Tekijä: McAuliffe, J
Julkaistu: (2020)

Baculovirus expression vector system for production of viral vaccines /
Tekijä: 300419 Vlak, J. M., et al.